CJC-1295 alternatives.

10 compounds compared to CJC-1295, ranked by published evidence tier and regulatory status, not by what's marketed hardest.

Why people look for an alternative

Half the people searching for CJC-1295 alternatives are really trying to escape a naming problem. The label covers two different molecules: the version with a Drug Affinity Complex that binds albumin and acts for a long time, and the version without it, sold as modified GRF 1-29, which does not. Neither has ever been approved by the FDA or any major regulator, development did not complete, and both are sold only as research chemicals and prohibited in sport by WADA as GHRH analogs. If what you want is a GHRH analog with regulatory standing, the field narrows to tesamorelin and to sermorelin's discontinued approval, not to another research peptide.

What you're comparing against
CJC-1295
F tier · 33/100Research / preclinical

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH), based on the first 29 amino acids of human GHRH (GRF 1-29) with several amino-acid substitutions that resist enzymatic degradation.

Ranked by evidence · strongest first
  1. 01
    Tesamorelin
    A tierFDA-approved
    Egrifta

    Acts through the ghrh signalling pathway, like CJC-1295. FDA-approved.

  2. 02
    Sermorelin
    C tierResearch / preclinical

    Acts through the ghrh signalling pathway, like CJC-1295. Research / preclinical.

  3. 03
    CJC-1295 DAC
    F tierResearch / preclinical

    Acts through the ghrh signalling pathway, like CJC-1295. Research / preclinical.

  4. 04
    Mod-GRF (1-29)
    F tierResearch / preclinical
    CJC-1295 no-DAC

    Acts through the ghrh signalling pathway, like CJC-1295. Research / preclinical.

  5. 05
    Human Growth Hormone
    S tierFDA-approved
    HGH · somatropin

    Same category: growth hormone. FDA-approved.

  6. 06
    ACE-031
    D tierIn human trials
    ramatercept · ActRIIB-Fc

    Same category: growth hormone. In human trials.

  7. 07
    GHRP-1
    D tierResearch / preclinical
    growth hormone-releasing peptide-1

    Same category: growth hormone. Research / preclinical.

  8. 08
    GHRP-2
    D tierResearch / preclinical

    Same category: growth hormone. Research / preclinical.

  9. 09
    GHRP-6
    D tierResearch / preclinical

    Same category: growth hormone. Research / preclinical.

  10. 10
    Hexarelin
    D tierResearch / preclinical

    Same category: growth hormone. Research / preclinical.

How this list is built

An “alternative” here means a compound that shares CJC-1295's mechanism pathway or sits in the same category, not a marketing substitute. Each is ordered by PepCue's evidence tier (a weighted 0–100 score across human data, safety, replication and regulatory clarity), then by whether it's actually approved. This is a research reference, not medical or purchasing advice: an alternative sitting higher on evidence does not mean it's right, safe, or legal for any given use. Reviewed June 1, 2026.

Comparing options with your provider?

PepCue keeps every compound, dose and lab in one private, provider-ready timeline, whichever one you land on.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page
Compounds